Publication:
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)

Simple item page
dc.contributor.authorde las Penas, R.
dc.contributor.authorBlasco, A.
dc.contributor.authorDe Castro, J.
dc.contributor.authorEscobar, Y.
dc.contributor.authorGarcia-Campelo, R.
dc.contributor.authorGurpide, A.
dc.contributor.authorLopez-Lopez, R.
dc.contributor.authorMajem, M.
dc.contributor.authorRodriguez, C. A.
dc.contributor.authorVirizuela, J. A.
dc.contributor.authoraffiliation[de las Penas, R.] Consorcio Hosp Prov Castellon, Serv Oncol Med, Avda Dr Clara 19, Castellon De La Plana 12002, Castellon, Spain
dc.contributor.authoraffiliation[Blasco, A.] Hosp Gen Univ Valencia, Serv Oncol Med, Valencia, Spain
dc.contributor.authoraffiliation[De Castro, J.] Hosp Univ La Paz Madrid, Serv Oncol Med, Madrid, Spain
dc.contributor.authoraffiliation[Escobar, Y.] Hosp Gen Univ Gregorio Maranon Madrid, Serv Oncol Med, Madrid, Spain
dc.contributor.authoraffiliation[Garcia-Campelo, R.] Hosp Juan Canalejo, Complexo Hosp Univ A Coruna, Serv Oncol Med, La Coruna, Spain
dc.contributor.authoraffiliation[Gurpide, A.] Clin Univ Navarra, Serv Oncol Med, Pamplona, Spain
dc.contributor.authoraffiliation[Lopez-Lopez, R.] Complejo Hosp Univ Santiago de Compostela, Serv Oncol Med, Santiago De Compostela, Spain
dc.contributor.authoraffiliation[Majem, M.] Hosp Santa Creu & St Pau Barcelona, Serv Oncol Med, Barcelona, Spain
dc.contributor.authoraffiliation[Rodriguez, C. A.] Hosp Univ Salamanca, Serv Oncol Med, Salamanca, Spain
dc.contributor.authoraffiliation[Virizuela, J. A.] Complejo Hosp Reg Virgen Macarena Sevilla, Serv Oncol Med, Seville, Spain
dc.date.accessioned2023-02-12T02:20:27Z
dc.date.available2023-02-12T02:20:27Z
dc.date.issued2016-12-01
dc.description.abstractChemotherapy-induced nausea and vomiting is one of the most worrisome adverse effects of chemotherapy for cancer patients. It can cause severe discomfort and affect the quality of life. In recent years, the incorporation of new drugs has increased the efficacy of antiemetic treatments in the control of emesis associated with chemotherapy. This guideline, in which we give some treatment recommendations with level of evidence and grade of recommendation, provides an update of the previously published guideline of the Spanish Society of Medical Oncology and represents our continued commitment to improving supportive care in cancer patients.
dc.identifier.doi10.1007/s12094-016-1583-0
dc.identifier.essn1699-3055
dc.identifier.issn1699-048X
dc.identifier.unpaywallURLhttps://europepmc.org/articles/pmc5138256?pdf=render
dc.identifier.urihttp://hdl.handle.net/10668/18652
dc.identifier.wosID389970300011
dc.issue.number12
dc.journal.titleClinical & translational oncology
dc.journal.titleabbreviationClin. transl. oncol.
dc.language.isoen
dc.organizationHospital Universitario Virgen Macarena
dc.page.number1237-1242
dc.publisherSpringer international publishing ag
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectChemotherapy-induced emesis
dc.subjectAntiemetic drugs
dc.subjectProphylaxis of emesis
dc.subjectSEOM guidelines of antiemetic drugs
dc.subjectEfficacy
dc.subjectEmetogenicity
dc.subjectPalonosetron
dc.subjectCombination
dc.subjectNetupitant
dc.subjectSafety
dc.subjectNepa
dc.titleSEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number18
dc.wostypeArticle
dspace.entity.typePublication

Files

Collections

SAS - Hospital Universitario Virgen Macarena

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía